As the main pathogenesis of psoriasis, IMQ stimulates epithelial cells and tissue resident macrophages and results in secretion of chemo-attractants which initiate neutrophil recruitment into lesion. IMQ induced epidermal expression of IL-17, IL-22 and CXCL8. Daily application of IMQ on mouse back skin induced inflamed scaly skin lesions resembling plaque type psoriasis. These lesions showed increased epidermal proliferation, abnormal differentiation, and epidermal accumulation of neutrophils in microabcesses. Synthetic diacylglycerol derivatives, 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) was studied for evaluation of its therapeutic efficacy on IMQ-induced psoriasis-like skin inflammation. PLAG has a prominent biological effect on amelioration in the IMQ-induced inflammatory disease and on attenuation of IL-17, IL-22, and MIP-2 expression in the dermal tissue of mice.
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Through an in vitro assay system, the effective eliminating of IMQ as a DAMPs molecule, terminating of successive chemokine and cytokine releasing, blocking of excessive neutrophil migrate activity by PLAG treatment was verified. Promoted resolution of DAMPs successively produced during tissue damage is very crucial function of PLAG for maintenance of homeostasis in the IMQ induced psoriatic skin disorder. Our studies suggest that orally administration of PLAG could be utilized as an effective therapeutic tool for skin inflammatory disease. Background: Anti-dsDNA autoantibodies are used routinely as disease activity biomarkers in lupus. However, current detection methods cannot inform immunoglobulin variable (IgV)-region composition, mutational status or clonal turnover. We have developed a novel proteomic workflow based on direct mass spectrometric (MS) sequencing of anti-dsDNA precipitins for molecular analysis of high-avidity anti-dsDNA responses. Here we perform molecular profiling of anti-dsDNA during a flare of lupus and use quantitative proteomics to track expression of dominant IgV subpopulations.
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Methods: Longitudinal serum samples were taken from a 59 year old woman with SLE who presented with a flare characterised by fever, toxic epidermal necrolysis (TEN)-like acute cutaneous lupus, oral ulcers, delirium and an anti-dsDNA >100 IU/ml (Farr assay). Serum anti-dsDNA immunoglobulins were sequenced by liquid chromatography (LC)-MS/ MS from purified precipitins over the course of the flare. Levels of specific IGHV subfamilies were quantified by multiple reaction monitoring (MRM)-MS using surrogate heavy-chain peptides. V-region peptide maps were analysed using Peaks V8.0 software and established databases.
Results: Baseline anti-dsDNA proteomes were oligoclonal with shared expression of heavily mutated IGHV subfamilies. Mutational profiles during the flare were consistent with continuous clonal turnover. MRM/MS revealed increased expression of dominant IGVH populations at the onset and during the flare; levels then trended towards baseline at remission. The dynamics of individual IgV subfamilies were variable within the flare consistent with a dynamic process of anti-dsDNA immune complex deposition.
Conclusion:
Precipitating anti-dsDNA responses during a flare are consistent with continuous antigen-driven clonal selection in germinal centres. Dominant heavy-chain signatures are increased during a flare and decreased at remission, demonstrating the utility of MS autoantibody profiling for tracking pathogenic clones currently invisible by conventional assay. Proteomic tagging of pathogenic anti-dsDNA clones reveals a molecular target for their therapeutic removal. In an effort to discover an anticancer agent, we identified a novel compound WCI-1004 effective against both UV-induced skin carcinogenesis and AD.
P66 A SMALL MOLECULE THERAPEUTIC AGAINST ATOPIC DERMATITIS AND UV-INDUCED SKIN CANCER
Methods: Oxazolone was used for the induction of AD on the skin of mice. For the detection of skin cancer, mice were either treated with TPA/DMBA or exposed to UV irradiation.
Summary of results: WCI-1004 showed more effective anti-skin cancer activity compared to 5'-FU, a representative skin cancer therapeutics as evidenced by TPA/DMBA-induced two-step skin carcinogenesis and UVinduced skin cancer animal models. Moreover, WCI-1004 reduced the expression of inflammatory atopic cytokines IL-4 and IL-13 and had a strong anti-AD effect in oxazolone-treated atopic mice model, with a comparable effect to Eucrisa, a recently developed AD treatment.
Conclusion:
Our data suggest the potential of WCI-1004 as a promising AD treatment as well as anti-skin cancer chemotherapeutic.
P67 FREQUENCY AND ASSOCIATIONS OF ANCA POSITIVITY IN PATIENTS PRESENTED AT AN INTERSTITIAL LUNG DISEASE MULTIDISCIPLINARY TEAM MEETING (ILD MDT)
Arthur Wong Results: 360 cases were presented between 2014-2017. ANCA were identified in 27 patients at a frequency of 0.075%. 15/27 patients were male. ANCA patterns were identified as cytoplasmic, perinuclear or atypical, with titres ranging from 1:20 to 1:160. Anti-myeloperoxidase (MPO) and anti-proteinase 3 (PR3) antibodies were detected in 6 and 3 patients respectively. Two of these patients were subsequently diagnosed with vasculitis and treated with immunosuppression. One patient with MPO antibodies had a clinical response to steroids without evidence of vasculitis. MPO antibodies normalised on serial testing in 1 patient. 18 patients were positive for ANCA by immunofluorescence only. None of these patients had evidence of vasculitis and varied clinical diagnoses were present. Radiological patterns included usual interstitial pneumonia (UIP) or UIPlike features (7 patients), non-specific interstitial pneumonia (NSIP) (5 patients), or other patterns (15 patients) including non-specific groundglass infiltrate, combined pulmonary fibrosis with emphysema, organising pneumonia or a micronodular infiltrate.
Conclusion: Anti neutrophil cytoplasmic antibodies are not infrequently identified in patients during investigation of interstitial lung disease and are associated with variable clinical features and radiology. Long-term observation is recommended due to the possibility of emergent vasculitis. Two patients in our cohort were diagnosed with organ-threatening vasculitis following the MDT review. The above highlights the importance of collaboration between respiratory physicians and immunologists and the utility of a multidisciplinary approach in interstitial lung disease. 
